FDA asks Merck for help with drug shortage; Low level hypertension unaffected by meds;

 @FiercePharma: Watson sues FDA for delay of generic Actos launch. More | Follow @FiercePharma

> The FDA says it is working with a Merck ($MRK) subsidiary and also looking to foreign manufacturers to find drugs to substitute for Sanofi Pasteur's bladder cancer drug TheraCys, which is in short supply. Story

> The FDA is issued a safety alert after the deaths of three children who took codeine following surgery. FDA Release

> Eisai susidiary Morphotek has opened a new pilot manufacturing plant in Exton, PA, to produce biological-based therapeutics to help accelerate early-stage clinical trials. Story

> Ranbaxy Laboratories says much of its future drug production for the U.S. and Europe will come from its plant in Mohali, India. Story

> Wockhardt has gotten FDA approval for its extended release tablets of Alfuzosin hydrochloride, used for treatment of enlarged prostate. Item

> The U.K.'s National Health Service reports that the number of prescriptions written for diabetes has grown by 50% in the last 6 years, while prescriptions overall have increased just 33%. Story 

Medical Device News

 @FierceMedDev: Venture capital funding for medical device firms declined 17% in Q2, according to PwC. More | Follow @FierceMedDev

 @MarkHFierce: An AdvaMed job placement initiative for military veterans has snagged some funding. Formal launch is at AdvaMed 2012. More | Follow @MarkHFierce

 @DamianFierce: KCI is selling its therapeutic support systems business for $275M. More | Follow @DamianFierce

> Speculation reigns on Medtronic M&A targets in China. Story

> Medical device VC shrank by 17% in Q2, PwC says. Article

Biotech News

 @FierceBiotech: When Herceptin gets under the skin--literally. More | Follow @FierceBiotech

 @JohnCFierce: AstraZeneca hands over $28M to team with Regulus on cardio pact. More | Follow @JohnCFierce

 @RyanMFierce: What does translational research mean in practice? Here's a good piece from the front lines in the U.K. More | Follow @RyanMFierce

> Eisai chief outlines Belviq sales effort, deal strategy. Spotlight

> Open-innovation projects turn old R&D wisdom 'on its head'. Story

> R&D experts applaud new initiative to validate biomedical studies. Article

> Struggling Tengion threatens bankruptcy as it scrambles for cash. News

Biomarkers News

> Drug-biomarker combo pinpoints prostate cancer. Story

> Genes pinpoint kids' bone cancer outcomes. News

> Alzheimer's disease blood test comes ever closer. Article

> Urine proteomics could pinpoint diabetic nephropathy. More

Drug Delivery News

> pSivida--focusing on delivery to the eye. Editor's Corner

> Oral nanoparticle vaccine could protect against HIV. Spotlight

> Hydrogel foams can deliver drugs for 6 months. More

> Nanoplexes deliver personalized medicine in cancer. Story

And Finally... A new study of drug treatment for low level hypertension suggests that drugs do not play a significant role in lowering heart attack and stroke risk. Story